Challenges in image-guided therapy system design by DiMaio, Simon et al.
Challenges in Image-Guided Therapy System Design
Simon DiMaio1, Tina Kapur1, Kevin Cleary2, Stephen Aylward3, Peter Kazanzides4, Kirby
Vosburgh5, Randy Ellis6, Jim Duncan7, Keyvan Farahani8, Heinz Lemke9, Terry Peters10,
Bill Lorensen11, David Gobbi10, John Haller12, Larry Clarke8, Steve Pizer13, Bob
Galloway14, Gabor Fichtinger4, Noby Hata1, Kim Lawson1, Clare Tempany1, Ron Kikinis1,
and Ferenc Jolesz1
1Brigham and Women’s Hospital, 75 Francis St., Boston, Massachusetts 02115
2Georgetown University, 2115 Wisconsin Avenue NW, Suite 603 Washington, DC 20057
3Kitware Inc, 28 Corporate Drive, Clifton Park, New York 12065
4Johns Hopkins University, B26 New Engineering Bldg, 3400 North Charles St, Baltimore, MD
21218
5CIMIT, 65 Landsdowne Street, Suite 200, Cambridge, MA 02139
6Queens University, Goodwin Hall, Kingston, Ontario, CANADA K7L 3N6
7Yale University, 310 Cedar Street, BML 332 New Haven, CT 06511
8National Cancer Institute, 6130 Executive Blvd. MSC 7412 Suite 6000 Bethesda, MD 20892
9University of Southern California, Los Angeles, USA
10Imaging Research Laboratories, Robarts Research Institute, London, Ontario N6A 5K8
11GE Global Research,1 Research Circle, Niskayuna, NY 12309
12NIBIB, Democracy Plaza Two, 6707 Democracy Boulevard Bethesda, MD 20892
13UNC, CB #3175, Sitterson Hall, Chapel Hill, NC 27599-3175
14Vanderbilt University Nashville, TN 37235.
Abstract
System development for Image-Guided Therapy (IGT), or Image-Guided Interventions (IGI),
continues to be an area of active interest across academic and industry groups. This is an emerging
field that is growing rapidly: major academic institutions and medical device manufacturers have
produced IGT technologies that are in routine clinical use, dozens of high-impact publications are
published in well regarded journals each year, and several small companies have successfully
commercialized sophisticated IGT systems. In meetings between IGT investigators over the last
two years, a consensus has emerged that several key areas must be addressed collaboratively by
the community to reach the next level of impact and efficiency in IGT research and development
to improve patient care. These meetings culminated in a two-day workshop that brought together
several academic and industrial leaders in the field today. The goals of the Workshop were to
identify gaps in the engineering infrastructure available to IGT researchers, develop the role of
research funding agencies and the recently established National Center for Image Guided Therapy
(NCIGT), and ultimately to facilitate the transfer of technology among NIH-sponsored research
centers. Workshop discussions spanned many of the current challenges in the development and
deployment of new IGT systems. Key challenges were identified in a number of areas, including:
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validation standards; workflows, use-cases and application requirements; component reusability;
and device interface standards. This report elaborates on these key points and proposes research
challenges that are to be addressed by a joint effort between academic, industry, and NIH
participants.
INTRODUCTION
The field of image-guided therapy (IGT)—sometimes also called image-guided intervention
(IGI) or image-guided surgery (IGS)—has evolved from early stereotactic methods to
modern multi-modal image-based navigation systems and has experienced many exciting
advancements, particularly in the area of minimally-invasive intervention. Much of the early
innovation occurred within the field of neurosurgery that has faced some of the most
challenging conditions encountered in modern surgical practice, particularly for the
treatment of brain tumors (Henderson and Bucholz, 1994; Bullitt, Jung et al., 2004). The
nature and structure of the brain, and many of the tumors that invade it, create a frustrating
compromise between tumor eradication and the sparing of functionally critical tissue (Claus,
Horlacher et al., 2005). Modern image-guidance techniques improve the visualization of
pathologies with respect to adjacent tissue structures during tumor resection. They are used
for precisely positioning and manipulating instruments and ablative devices. This integrated
image-based approach has been adopted in many other clinical application areas and now
involves advanced intra-operative imaging, image registration, image segmentation,
visualization, navigation, and minimally-invasive ablative therapies and robotics (Shen, Lao
et al., 2004; DiMaio, Archip et al., 2006).
The field of IGT system development has been advancing rapidly: major academic
institutions and medical device manufacturers have produced IGT technologies that are in
routine clinical use, dozens of high-impact publications are published in well regarded
journals each year, and several small companies have successfully commercialized
sophisticated IGT systems. In ad-hoc meetings held between several investigators in IGT
over the last two years, a consensus emerged that to take the research and development
effort in IGT systems to its next level of impact and efficiency a few key areas must be
addressed collaboratively by the community. These meetings culminated in a two-day
workshop that brought together several academic and industrial leaders in the field today,
with discussions spanning many of the challenges currently faced in the development and
deployment of new IGT systems. These challenges involve identifying gaps in the
engineering infrastructure available to IGT researchers, developing the role of research
funding agencies and the recently established National Center for Image Guided Therapy
(NCIGT), and facilitating the transfer of technology among NIH-sponsored research centers.
Four specific key challenges were identified in this meeting, namely: (1) How to increase
the creation and exchange of reusable components—IGT systems are complex and not every
group should have to construct a platform from the ground up. The tool development
process needs to be made more efficient by leveraging and improving existing toolkits. (2)
The need for performance standards for validation. We must have a common understanding
of how to evaluate the performance of an IGT system and its components. A fundamental
point that must be understood is that mission-critical software is evaluated not by its average
performance but by its worst-case performance. (3) The need for increased awareness of the
utility of use-cases and surgical/interventional workflows that is critical to building
clinically acceptable IGT systems. (4) The need to motivate manufacturers to provide
Application Program Interfaces (APIs) and research interfaces for their software/devices.
In the remainder of this report we present a summary of the discussions that took place at the
breakout sessions of the workshop on topics covering: Workflow, Validation, Tracking, and
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Robot Interfaces—identified by the authors as important areas for in-depth study of IGT
system challenges (Section 2), followed by a synthesis of the key research priorities that
were identified in these discussions (Section 3.1), and recommendations made by the
participants for the role that the NIH (Section 3.2) and the NCIGT (Section 3.3) can play in
the development of IGT systems in the future.
TECHNOLOGY FOCUS AREAS
2.1. IGT workflow design
The science of workflow gained prominence in the 1970s as a tool to study the movement of
documents in businesses. In the business setting, the goal of workflow analysis is to model
document movement in such a way as to evaluate efficiency, quantify latency, and thereby,
drive the allocation of resources. For example, in medical data management, the science of
workflow is used to study the movement of patient records, procedure requests, insurance
forms, and billings through hospitals.
More generally, the study of workflow is the analysis of task and resource scheduling: what
tasks are needed to be performed, what resources are needed for each task, what orderings
and synchronizations are needed between tasks, and how tasks are tracked. For image-
guided therapies, workflow analysis has two primary applications. Workflow analysis can be
applied to choreograph the movement of clinicians and technicians (“physician workflow”)
so as to reduce procedure time and patient risk (Dickhaus, Burghart et al., 2004; Jalote-
Parmar, Pattynama et al., 2006). Workflow analysis can also be applied to study the
movement of information and images within the computer that drives the image displays
(data workflow) so as to speed processing and increase accuracy (Paggetti, Martelli et al.,
2001).
During workshop discussions, the concept of workflow was primarily focused on physician
workflow. The rationale for this focus was that by understanding and quantifying physician
workflow, developers will be better able to design and compare user interfaces and data
workflows in IGT software. For example, storyboarding—in this context—is the process of
studying human-computer interactions by prototyping the user interface and its associated
user interactions in a series of slides, such as in presentation software like PowerPoint. This
is an outstanding means for expressing workflow and fostering communications between
computer scientists, application developers and clinicians. .
This section describes highlights from our workshop discussions of the value of workflow,
workflow analysis and templates.
Workflow analysis and value—Workflow is an integral part of risk analysis and
validation for IGT applications. Focusing on workflow aids the development of re-usable
IGT libraries and applications and leads to the development of model-driven architectures.
Therefore, our goal in software systems development is to create model-driven IGT libraries
and applications that facilitate software review, test, reuse, and integration.
Methods for determining performance metrics, such as accuracy and time estimates during
workflow simulation, as well as in the operating room, need to be developed. These methods
will in turn need to be validated against measures acquired during phantom studies and
actual procedures.
Workflow templates—The concept of a workflow template or model creates a framework
in which applications can be developed or instantiated with specific algorithms that match
the application’s tasks. This modularity is inherent in the data workflow of the Insight
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Toolkit (ITK), for example (ITK, 2007). Its utility for IGT physician workflow for human-
computer interactions was studied by Trevisan et al. (Trevisan, Vanderdonckt et al., 2003).
He concluded that as few as four workflow templates are enough to model most image-
guided surgery systems. From this it appears that Petri Net representations of workflow are
frequently overly flexible and complex for most IGT applications and that the use of
templates allows complexity to be appropriately managed.
The research challenge is to develop a theoretical and practical foundation for adapting
workflow templates for a specific IGT application that is specialized to the clinical site,
physician, and/or patient. This adaptation must ensure that options for problem solving and
contingencies are not limited or overly constrained by the workflow template in the
operating room during surgery.
Workflow execution models—Once workflow templates and adaptation mechanisms
have been developed, it will become necessary to build a workflow execution model to
translate workflow descriptions into functional data flows and user interfaces, as well as to
enumerate and handle error conditions. The consensus amongst several developers of
existing IGT toolkits and interfaces was that this execution model should be truly GUI and
toolkit independent, cross-platform, and open-source, such that it can form a common basis
for bridging existing IGT toolkits and application frameworks, including the 3D Slicer (3D
Slicer, 2007), IGSTK (Gary, Ibanez et al., 2006; IGSTK, 2007), SIGN (SIGN, 2007), and
others.
2.2. Validation of New IGT Approaches
In general, system specifications are developed through a “requirements elicitation” process.
However, clinical therapeutic tasks are complex and a new system design can typically only
be characterized in limited ways. This has a significant impact on subsequent testing and
validation, as system requirements and specifications serve as a natural baseline for
evaluation. There is a tendency to equate greater precision with improved clinical outcomes,
which is not always valid. Therefore, specifications may be too tight for a particular clinical
need. In contrast, operator acceptance alone is too low a standard. After bench tests meet





The conundrum of specifications is that—prototypes and products are built to meet
design goals, which are represented by specifications. In developing new techniques, there is
an implicit assumption (which should be verified under use-testing, as described below) that
meeting the specifications will create a tool or system that enables superior clinical results.
Here we explored two levels of system validation, namely user evaluation and clinical
outcome testing.
Initial user evaluation—Comparative studies may be undertaken, successively, through
retrospective analysis, simulators, phantoms, animal models, and human subjects. Present
generations of simulators are insufficiently realistic to provide much assurance that a new
device design is better than an old one for a complex task. Animal models provide much
more realistic test conditions but suffer from the obvious differences in anatomy and
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physiology when serving as surrogates for humans; therefore, some level of human testing
will be necessary.
Various groups are using techniques developed in other fields to characterize system
performance. Several studies of simulators for laparoscopic surgery training have been
conducted. More recently, tests have been made under actual OR conditions in animal or
human models. For example, the Hager group at Johns Hopkins University has analyzed the
kinematic data in the DaVinci system (Burschka, Corso et al., 2005), and the Vosburgh
group at CIMIT/BWH has studied the performance kinematics and also the display utility in
laparoscopic and endoscopic systems (Vosburgh, Stylopoulos et al., 2007).
At this level, various possible system error modes can be delineated and avoidance,
mitigation, or response plans developed.
Clinical Outcomes—The standard method for validating a new therapy is by evaluating
its performance relative to standard practice. Almost always, a prospective clinical trial is
necessary to validate a new approach. As examples of the level of effort that is traditionally
required, consider the studies by Shapiro et al. for validating new methods for the treatment
of hybrid astrocytoma (Shapiro, Green et al., 1989). These took five years, and were well
supported with a clinical infrastructure. In a Scottish study of 107 liver resections (Schindl,
Redhead et al., 2005), the fraction of liver tissue remaining after various procedures was
measured. The study was helped by the fact that liver resections are very indicative of near-
term outcomes.
In comparison to testing new surgical therapies, drug or vaccine trials have defined end
points: markers or direct measurements such as tumor size. Controls may be easily
implemented through placebos, which are much simpler than sham surgery. Drug trials are
primarily interested in finding side effects; however, for surgical devices the standard has
been lower. Surgical side effects (complications) are limited in number and are somewhat
predictable.
Clinical outcomes are difficult to measure, and proper control groups are difficult to
establish. It is often challenging to develop adequate patient numbers to give statistical
power, particularly for identifying rare and unsafe conditions. Additionally, multi-site
studies are needed for eventual FDA approval. This complexity may drive the adoption of a
partitioned approach, in which anecdotal analysis is combined with statistically valid tests
on lower dimensional factors. A model is then required to combine these dissimilar
observations. Thus, as was stated: “one needs standard deviations but also the estimate of
the number of dimensions.” In addition, investigators will be well served to find creative
ways to study multiple approaches simultaneously so that some level of serial analysis may
be precluded.
2.3. Tracking and Localization Systems
In the context of image-guided intervention, the term “tracking” is a broad one that can
include the act of localizing surgical instruments, therapy devices, patient anatomy, tissue
targets, and even medical personnel as they move about the operating room. Workshop
participants focused primarily on systems that track the position and orientation of
instruments and devices (Welch and Foxlin, 2002), for the purpose of establishing and
maintaining a correspondence between medical images and the surgical field of view while
navigating instruments during surgery. Our discussions highlighted challenges in two areas
of interest, namely: i) performance assessment and validation; and ii) open systems and
Application Programming Interfaces (APIs).
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Assessment and validation—There are many ways to evaluate and report the
performance of a tracking system, and testing methods are very much application-dependent
(Nafis, Jensen et al., 2006). Unfortunately, to date there has been no consensus on tracking
requirements. Vendors report that they are reluctant to define requirements or standards, due
to their exposure to liability, and the authors are not aware of any standards body that
currently exists to govern performance specifications specifically for clinical tracking
systems. As a result, it is difficult to compare systems based on their reported performance
parameters. For example, typical performance metrics and measures include “average error”
and “root mean squared error” with their associated standard deviation or confidence levels.
These measures are of little use without knowledge of the testing procedures employed. For
example, tracking accuracy will usually vary over the active workspace and depend upon the
state of motion of the tracker. For electromagnetic trackers, one needs to further define the
testing environment as magnetic distortions or electromagnetic interference can have
significant impact on performance. Key technical performance criteria include: static
accuracy, dynamic accuracy, static and dynamic precision, temporal resolution (i.e., update
rate), spatio-temporal stability, latency, environmental sensitivity, interference between
devices, and confidence reporting (the ability of the tracking system to “self-assess” and
report the quality of its measurements).
Clearly, without standardization of testing methods, the combination of these criteria
presents an intractable performance testing and specification problem. Testing methods for
medical trackers should be based on clinical requirements and use cases since this is the
context in which they will be operated. Unfortunately, clinical requirements are also difficult
to determine as demands vary from medical procedure to procedure and from physician to
physician.
Related to the problem of assessment and validation is the reporting of confidence measures
by the tracker hardware during operation. In medical applications it is important to have a
continuous assessment of the quality of the measurement, with immediate notification of
significant degradation. At present, some systems associate a confidence measure with
tracked coordinates; however, these confidence measures are not consistent between vendors
and are difficult to interpret quantitatively. Workshop participants felt that the availability of
richer performance measures would be useful for developers. Industry participants indicated
that in many cases, such information is available within their systems, but can be extensive.
Some dialogue between the scientific community, application developers and device
manufacturers is required to define the scope of this performance reporting, such that
suitable data interfaces can be defined.
Open Systems and APIs—Just as there is an absence of standards for assessing the
performance of medical tracking systems, there are currently little or no software and
hardware interface standards between vendors and devices. While each tracking system is
different in its manner of operation, there is a need for a common API that can be used by
software developers—this is particularly important in applications that integrate/fuse
multiple tracking systems, and where some coordination or synchronization is required
between systems (i.e., hybrid tracking).
The open source model may be appropriate for helping to drive an “open interface standard”
between devices, by giving vendors and developers a common software interface
framework. There are a number of concerns with this model:
• Interface requirements would need to be specified by determining a common set of
functionality required by users and developers,
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• Regulatory approval and certification may be difficult to obtain; therefore, effective
strategies for validating open software systems will be necessary,
• The deployment route through the open-source community is unclear, and
• The seat of responsibility/liability is unclear.
However, it should be noted that there is existing use of open-source software by vendors of
medical devices(GEHealthcare-MicroCT, 2007; GEHealthcare-Specimen-MicroCT, 2007),
and that this could serve as precedent. In such cases, open-source projects have been
adopted and frozen for internal validation and deployment by vendors. An example of a
promising open-source interface framework for tracking systems is the OpenTracker library
(Reitmayr and Schmalstieg, 2001; Reitmayr and Schmalstieg, 2001; OpenTracker). Industry
support for a common API will require some investment in time and resources. This means
that vendors cannot be expected to support multiple APIs; therefore, it is necessary to build
consensus between researchers and developers to support a single open-source interface, or
at least a common specification of its requirements.
2.4. Interfaces to Image-Guided Robots
Robots have assisted with surgery since the early 1990s, although currently their use is not
as widespread as that of many other computer-assisted surgical technologies, such as
navigation systems. However, it is clear that these technologies hold some important
potential benefits for image-guided intervention, including:
• Improved visualization and dexterity in areas that are difficult to reach, e.g., for
minimally invasive surgery or for surgery inside CT/MR scanners,
• Reduction of radiation exposure to surgeon, e.g., by removing the surgeon’s hand
from the fluoroscope field of view,
• Provision of a “third hand”, e.g., to hold cameras, retractors, etc,
• Increased accuracy in carrying out a surgical plan, e.g., the surgical equivalent of
CAD/CAM; and the ability to work with smaller structures in microsurgical tasks,
e.g., by motion scaling and/or tremor reduction, and
• Improved safety via the use of virtual fixtures (“no fly” zones).
Workshop participants identified a number of key research, development and deployment
challenges in this area, namely: infrastructure for rapid prototyping, safety and validation,
and control of commercial systems for research.
Infrastructure for rapid prototyping—The need for infrastructure support was raised
by both industry and academia, though the specific needs are quite different. Manufacturers
of surgical robots are interested in an infrastructure that would enable better technology
transfer. This would include the ability to more rapidly integrate new technologies—such as
those developed in academia—with their robots. Industry also expressed an interest in the
software “best practices” that have evolved particularly in the open source community (e.g.,
DART – the automated nightly testing framework initially developed for ITK) (DART,
2000).
Researchers expressed the need for an infrastructure to enable them to build robotic systems
and applications to achieve their research goals. Significant hardware and software
infrastructure is required to support research, particularly in IGT areas that involve medical
imaging and navigation. Hardware support can include a number of different imaging
systems (CT, MRI, X-ray, ultrasound, etc.) and several 3D tracking systems based on a
variety of technologies (optical, electromagnetic, etc.). Software support includes standards
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such as DICOM, as well as open source packages such as VTK, ITK, DCMTK, 3D Slicer,
OpenTracker, and IGSTK. In contrast, there is no off-the-shelf robot system—with an open
interface—that is suitable for medical use and no mature open source packages for robot
control.
Safety and validation—Several workshop participants raised issues about validation and
regulatory approval, particularly in regards to the use of open source software, such as how
this software will be validated and who takes responsibility for maintenance. During the
discussion, it was suggested that the best practice for medical device manufacturers wishing
to use open source software is to capture a “snapshot” of the software and validate their use
of it as they would do for any third-party software. The manufacturer should apply its
standard software change-control procedure and continue to use this version of software
until it captures and validates a newer version.
This discussion also focused on the need for common phantom models that could be used to
benchmark or validate systems being developed. This is a large effort due to the number of
different target organs and surgical procedures that could be addressed by robotic systems.
An ASTM working group (F04.05) is already developing a standard for measuring and
reporting accuracy of computer-aided surgery systems; however, its initial focus is on the
measurement accuracy of the underlying tracking technology (e.g., optical, electromagnetic,
or mechanical system). Ultimately, we need phantom models that are more representative of
clinical conditions since validation of clinical performance is paramount.
It was also noted that there is no standard for medical robot safety. This is a challenging area
because safety requirements are very much application-dependent. In some applications,
such as hip or knee replacement surgery, an occasional “glitch” of several millimeters may
be tolerable, whereas in many other areas (e.g., brain surgery) this could be extremely
hazardous.
Controlling commercial systems for research—Representatives from both industry
and academia agreed on the importance of bidirectional control of commercial systems for
research purposes. This includes the need for integrating image feedback with robot
systems. Therefore, it is not only important to have bidirectional control of commercial
robots, but it is also important to have it for other devices such as intra-operative imaging
systems.
The existence of external control functions requires careful validation, even if only intended
for research purposes, because they must not compromise the performance of the device for
its intended use. Clearly, there are safety and regulatory issues that must be resolved.
RESULTS AND DISCUSSION
From these technical focus areas, we have summarized a number of key research priorities
for IGT systems development, as well as the role of funding agencies—such as the NIH—
and the role of the NIH-funded National Center for Image Guided Therapy in catalyzing
activity.
3.1. Research Priorities
Requirements for IGT Systems—Explicit performance requirements should be
determined from the end users of these systems, i.e., the physicians and their medical
personnel. Clinical needs may need to be interpreted by application developers to distill
technical requirements; however, standards must come from the applications themselves.
New methods are required for capturing and developing these requirements. In turn,
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common standards will help to drive—and make consistent—procedures for performance
assessment and validation.
Hardware and Software Standards for IGT—Concerns raised by the FDA regarding
the use of open-source software indicate that further discussions are necessary between
industry, academia, and the FDA. Although some manufacturers have experience with open-
source software, there is no “standard” procedure for incorporating this software. One
possible outcome could be an FDA guidance document on the use of open-source software
(as currently exists for the use of COTS software (FDA, 1999). The dialogue should also
include the topics of open architectures for, and bidirectional control of, medical devices.
Because devices such as tracking systems and interventional robots require so much
specialized hardware, their use of open-source software may be more limited than in other
fields, such as medical imaging. Nevertheless, even if a robot uses custom or proprietary
software, the participants agreed that there is still great value in having open architectures
and interface standards. This is also true for imaging devices, especially 2D and 3D
ultrasound, which today have very limited research interfaces. This need for interfaces stems
from the move toward more complex hybrid systems. In many cases, multiple standards do
already exist; however, there is not enough agreement to facilitate and sustain collaborative
development. There will always be competing standards; however, it is up to the
marketplace which of these will prevail. Based on available precedents, it seems wise to
allow “open source” software technologies to be the driver of “open architecture” or “open
innovation” trends in IGT, at least initially.
Some work is required to understand and develop the value proposition for industry to invest
in opening interfaces and standards involving their devices. For example, therapy is a far
smaller niche than diagnostic imaging today; therefore, it is not clear how to convince
manufacturers/vendors of imaging systems to invest in new methods for which long-term
pay-off is unclear, particularly when significant engineering effort and cost is required to
support standards. The current incentive to industry is that they can take advantage of
resources and brain power that are being brought to bear by the research community;
however, better matching between the research community and industry is required so that
mutually beneficial progress is made. This requires a coordinated approach from the
research community.
A further need within the research community is for greater compatibility between software
toolkits for image guidance, with minimal duplication between toolkits, as far as it is
possible. Following a number of established toolkits for visualization and image processing,
such as VTK (VTK, 2007) and ITK (ITK, 2007), several efforts for building application
software frameworks for IGT applications are already underway, including 3D Slicer (3D
Slicer, 2007), IGSTK (IGSTK, 2007), and SIGN (SIGN, 2007). While it is unlikely that one
single IGT toolkit will emerge for all applications, it would be helpful for us to align these
efforts, to ensure optimal compatibility and interoperability.
Information and Communications Technology in IGT—Image-guided
interventional systems typically consist of a number of components, devices and software
models that are connected through data and information interfaces of various forms. A
number of these components have been developed in academic and industrial settings and in
most cases exist as stand-alone systems with specific ad hoc proprietary or vendor
interfaces. They can be considered as islands of IT engines and repositories with varying
degrees of modularization and interconnection.
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Information and Communications Technology (ICT) concepts have been studied for the
purpose of mitigating the complexity of system integration across disparate interfaces. For
example, the “Therapy Imaging and Model Management System” (TIMMS) is one attempt
to deal with the information intensive “Digital Operating Room” by complementing the
image-centric world view of the classical PACS technology with an Information Technology
model-centric view (Lemke and Vannier, 2006).
The collaborative development of highly modular systems will require that we develop ICT
standards. An example of a relevant developing standard for medical imaging is that of
DICOM, and the work of DICOM Working Group 24 (WG24). It is interesting to note that
this is not only being driven by the traditional DICOM community, but that workgroups and
committees now include surgeons, IGT engineers, etc. Therefore, the IGT community must
be more active in this area to take advantage of the momentum that exists in the
development of this standard. At the very least, if DICOM WG24 does not fulfill the basic
requirements of IGT, then it would provide a good basis for initiating a workgroup for
developing imaging and modeling standards for IGT, using ICT concepts and
methodologies.
Consistent Evaluation and Validation Methods—Between the cultural extremes of
the bench engineer or scientist and the practicing clinician, we should build teams that can
move us toward a unified philosophical approach and a mutually agreed representative
paradigm for effective validation. This will not be static but rather will be improved over
time.
An important first step will be to focus on developing effective methods to define
requirement specifications for IGT systems as well as gold-standards. This will help to lead
us to a consensus on how to evaluate and validate IGT systems from the low-level technical
(e.g., tracking accuracy) to high-level clinical (e.g., survival/mortality rates). This clearly
highlights the need for mechanisms to pool our results so that the community can converge
on the most effective strategies and evaluation metrics. Note that the first objective of
validation is to determine suitable measurements and metrics, while the second objective is
to compare these metrics to the specified requirements. Without this context, the
measurements are meaningless.
Knowledge Databases and Algorithm Repositories—Workshop participants
identified knowledge databases and shared repositories as means to address some of the
difficulties in reaching consensus on IGT requirements, standards and validation methods.
Traditionally, academic journal publications have filled the need for sharing results and
progress within research communities; however, the nature of IGT research and
development means that we need to establish more extensive mechanisms for sharing and
building upon progress in the field.
We need to develop algorithm repositories for open-source IGT software/hardware
solutions, while leveraging existing toolkits to generate awareness of and access to existing
algorithms. Open-source software is defined as being: (i) freely available to use, and (ii)
distributed within a community of contributors. Therefore, the purpose of these repositories
is to create awareness of existing technologies, as well as a forum for improvement and
natural selection of superior approaches via the open-source mechanism. Similarly,
repositories of IGT hardware design principles and knowledge repositories should also be
considered.
The concept of “open data” is closely related to open source, in the sense that it provides a
context within which to compare and validate algorithms and methods. Image and data
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repositories have already been developed for medical image analysis (Holmes, Workman et
al., 2005) any may serve as a template for the IGT community. For example, note the impact
of the Fitzpatrick registration database (Fitzpatrick, West et al., 1998). To facilitate such
data collection and dissemination, clinical researchers should be encouraged to design their
IRBs to broaden the access to outcomes and data, so that the results can be used more
widely and more effectively. Patient advocacy groups may also support mechanisms to
make data and outcomes available for patients to share if they wish, just as it is possible for
them to donate their blood and tissue.
Collection and dissemination of case studies and data can be time consuming and expensive,
particularly if it is not part of standard clinical practice. Therefore, it may be helpful for the
research community to develop uniform methods and tools for efficient data gathering with
minimal overhead. As open-source systems become more widely adopted, such data
gathering methods could be built in.
A library of reference workflows may also be of great benefit to the IGT community. For
this, we will require standard tools and procedures for: (i) manually recording the actions of
physicians and technicians in the OR (Siddoway, Ingeholm et al., 2007); (ii) for
interviewing physicians to collect workflow descriptions for a variety of procedures; and
(iii) for collecting data that is already automatically recorded by commercial IGT systems
such as the StealthLink (Medtronic) and VectorVision (BrainLab).
3.2. The Role of the NIH in the Development of IGT
The NIH continues to play an important role in the support of research, development and
deployment of IGT technologies and systems. Based on the outline of current research
priorities presented above, the following activities were proposed as a means by which the
NIH can further help to stimulate activity and collaboration within the community.
• Consider formation of a focused study section for IGT. To spark this action, it
would be helpful to determine how many IGT-related proposals are currently
entering the NIH review process. Such tracking is difficult due to the absence of
codes for specific technologies as there are for diseases. Therefore, our priority is to
define consistent keywords that can lead to codes for identifying IGT projects.
• Stipulate requirements for open-source software in RFAs and PAs to stimulate
dissemination and sharing of methods and data. This will help to create an
environment that is conducive to collaboration and consensus-building. Some care
may need to be taken here to protect small business. Rather, emphasis should be
placed on funding common open-source infrastructure that researchers and
developers can leverage to add their own value and intellectual property. This will
ensure that open-source infrastructure will be an enabler for technology start-ups,
as well as the academic research community. What this community clearly lacks
now is consensus and support for standards and infrastructure.
• Sponsored workshops should host open-source demonstrations and tutorials to
create incentive and opportunity for small technology companies to become
involved.
• Program Announcements and RFAs should be more explicit in their requirement
for validation plans. In addition, it was felt that the NIH and the broader research
and development community work together toward standard models for these plans
and criteria for their evaluation.
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3.3. The Role of the NCIGT in the Development of IGT
The National Center for Image Guided Therapy, sponsored by NCRR, NIBIB, and NCI at
the NIH, is an important vehicle through which progress can be made in the research
priorities listed above. Specific activities may include:
• The Center can be used to maintain and distribute consolidated knowledge
databases of relevant open-source projects as well as case studies, benchmarks,
performance metrics and validation methods. To do this, the NCIGT can host
workshops and symposia designed to stimulate discussion and convergence within
the community. There is a possible role for NIST in establishing standards, as well
as phantoms and procedures for validating IGT sub-systems. Therefore, such
consolidated knowledge databases could be extremely helpful for building
consensus on standards.
• Investigation and clarification of the scope of standards and regulatory bodies—
such as the US Food and Drug Administration—in governing requirements for IGT
systems and technologies.
• By fostering the development of software toolkits for image-guided systems
(beyond VTK and ITK), the NCIGT should take the lead in developing functional
specifications and by identifying the initial contributors to this effort, perhaps based
on the knowledge repositories described above. Ultimately, these toolkits should
define the standard interfaces between technologies.
• Finally, it is necessary for us to identify respected members of the IGT community
who can champion and support methodologies and standards. These individuals
should collectively represent the views of medicine, engineering and research. The
NCIGT is in a unique position to identify such champions, to bring them together
in dialogue and to disseminate their views and recommendations through
publication, reviews and workshops.
CONCLUSION
The October 2006 workshop provided a forum for discussion between thought leaders in
academia, industry and at the NIH on the state of the art in IGT systems engineering.
Participants discussed current challenges in the development and deployment of new IGT
systems, identified gaps in the engineering infrastructure available to IGT researchers, and
provided recommendations to the research funding agencies at the NIH and the NCIGT.
Four specific key challenges were identified in this meeting: (a) Increasing the creation and
exchange of reusable components of IGT systems. (b) Developing a common understanding
of performance standards and validation of IGT Systems and their components. (c)
Increasing community awareness of the value of use-cases and surgical/interventional
workflows for building IGT systems that are clinically acceptable. (d) Providing clear
motivation to manufacturers to provide Application Program Interfaces (APIs) and research
interfaces for their software/devices. Above all, participants strongly felt the importance of
holding regular forums such as that reported here, to continue to refine the requirements for
IGT as the technology develops, and to maintain an active dialogue between researchers and
industry.
The challenges identified in this meeting span the breadth of IGT, stretching well beyond its
early origins in neurosurgery, into many areas of contemporary therapy/surgery. Therefore,
it is certain that research and development work aimed at addressing the research goals and
challenges outlined in this paper, will have significant impact on the future of clinical
practice.
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